Health claims are engineered into the starch, and there are two ways to do it
1 / 5
Low glycaemic index, high protein and high fibre recur across the whole field, and the mechanism claimed is nearly always the same. Slow the rate at which starch breaks down, either by wrapping the granule in fibre and protein or by driving the starch into resistant forms.
Market
Protein is the one health claim commercialised at scale, and the IP is not with the brands
2 / 5
Nissin put Cup Noodles Protein on sale nationwide in February 2026 at 16 g a cup for $1.33, over twice its standard product. Huel entered with ramen at 25 g and 40 g of plant protein per pot. Ottogi's high-protein cup noodles sold over a million units in a month. Betagro extruded noodles from chicken breast, and Pulmuone launched high-protein oat noodles.
Strategy
The claims being built are the ones that cannot be labelled where the work is filed
3 / 5
Low glycaemic index, blood-sugar regulation, botanical actives for sleep and fatigue: these are health functions, and China reserves health-function claims to registered health foods. The effort converts into nutrition claims the rules do allow — high protein, high fibre, low sugar — and into the mandatory panel. A GI labelling standard is in draft and in approval, and it restricts which products may carry the claim at all. The reformulation is real and the claim it was built to carry is not available, which pushes the reward toward the parts of the work that need no claim.
Research
The process route to a low-GI noodle is published science
4 / 5
Heat-moisture treatment of high-amylose starch raising resistant starch in triticale noodles, process-induced modification of potato starch shifting the digestible fraction, modified okara cutting rapidly digestible starch in noodles, pregelatinised white kidney bean starch reaching a low estimated glycaemic index. The mechanisms are published, by groups in Thailand, Israel, Indonesia and China. What the filings add is the specific combination of ingredient, schedule and machine.
Market
Sodium is the only claim with a date on it, and reduced-salt lines are already mainstream
5 / 5
Singapore extends Nutri-Grade to sodium and saturated fat in instant noodles from mid-2027, with front-of-pack marks mandatory for grades C and D and advertising banned for grade D. Thailand is preparing a tiered salt tax with instant noodles in a phased rollout. WHO relaunched its SHAKE package in May 2026, and the FDA finalised a salt-substitute rule in October 2026 alongside Phase II voluntary targets across 163 food categories.
Research
What is being built
Documents by area
1538
1460
1401
1013
864
222
89
35
25
Market
What reaches buyers
The category is growing on price and mix, and the claims being sold are the simple ones
China's instant noodle market reached 184.99 billion yuan in 2025, up 7.9%, and the growth is coming from price and mix rather than volume: mid- to high-priced products are growing at roughly 11.6% a year, several times the low-priced segment, and the above-5-yuan band is approaching half the market. Non-fried formats are the fastest-moving part of that shift, put at 52% of the market with 18–20% annual growth forecast.
Strategy
Where the money goes
The claim is moving off the recipe and onto the line and the pack
The field is converging on one move: make the claim a property of how the product is made rather than what is in it. The filings claim the ingredient list together with a kneading, steaming, setting and drying sequence, and the claim holds only if the sequence is reproduced. Sodium is handled in the seasoning and the pack, not the noodle recipe. Shelf life is bought with fermentation, pH control, barrier film and retort rather than with preservatives. The investment is going into process capability and packaging, and the ingredient list is becoming a liability as much as an asset, because a claim resting on an added functional ingredient has to declare it.